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of Nottingham published one of the very first
electronic journals), it seemed clear that researchers would embrace the new technology to
help them to collaborate and share their results
more efficiently. I expected that the whole
paradigm of publishing would change rapidly,
and that the peer review and dissemination
would be covered by research grants and that
results would be made freely accessible. This
is now happening and is called open-access
publishing. It is just that the change has taken
a decade or two longer to actually come about
than I expected.
ATG:  What trends are emerging in openaccess journal publishing?
DK: Open-access publishing is basically
a growing subset of STM publishing, so it is
subject to the same trends. Researchers are
being pressurized to publish more and more.
This leads to a pressure on peer reviewers
and on Editors, who need to continue to apply
the same high standards of peer review to an
increasing number of incoming submissions. It
also puts pressure on subscription journals who
are having to reject papers that they would never
have done in the past, because of page budgets,
and these papers are now being channeled to
open-access journals, which do not have the
same limits on space. This has been the motivation for the launch over the last 12 months
of Scientific Reports from Nature Publishing
Group, BMJ Open, G3 from the Genetics Society of America, Open Biology from the Royal
Society, and many similar journals.
At the same time research budgets in Europe
and North America are being cut, while those
in the emerging markets are increasing rapidly
— with the output of high-quality scientific
papers from countries such as China, Brazil,
and India growing extremely rapidly. So the
demographics of the authors are changing,
and they have different needs which we need
to cater for.
The other major trend is the move towards
Open Data — to quote a recent blog on our
site from Alex Wade of Microsoft: “scholarly
communication can and should evolve from
static and disparate data and knowledge representation, as embodied in today’s typical PDF
representations of research papers, to a rich
integrated content which grows and changes
the more we learn.” BioMed Central is again
leading the field in this regard.
ATG:   What has been the impact of
Springer’s purchase of BioMed Central on
the attitudes and business plans of BioMed
Central?
DK: It is the difference between being a
start-up company owned by an individual and
being part of a large international business.
Springer is interested in the long-term future
of the business so has invested substantially
in BioMed Central and allowed us to take a
longer-term strategic outlook. Springer’s infrastructure is really helping us to realize our
potential for growth. For example, Springer’s
global network of offices allows us to have staff
in key locations, such as China and the U.S., as
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Born and lived: Born in Manchester, lived in Manchester, London, Utrecht,
Amsterdam and Oxford.
Early life: My parents (a Professor of theoretical astrophysics and a Mathematics teacher) encouraged me to be curious and question everything. Has got me
into hot water from time to time.
Professional career and activities: STM publisher through and through.
Started In book and journal production, moved into acquisitions and journal management. Ten years with the Thomson Corporation learning to be an electronic
publisher. Tried to leave the industry and become a psychotherapist, but STM
publishing pulled me back, when I found my dream job (this one!).
In my spare time: If I had some, I would spend more time with my partner
and dog, play the piano, walk in the mountains, go to the gym, sing in a choir,
read more books, cook gourmet food.
Favorite books: The Bone People, A Fine Balance, The Blind Assassin.
Pet peeves: People who don’t question things.
Most memorable career achievement: That’s for others to assess.
Goal I hope to achieve five years from now: Still to be enjoying my job
as much as I am now.
How/where do I see the industry in five years: I am continually surprised by the glacial speed of change within the academic publishing. Really
nothing much has changed in 300 years. Granted, electronic communications
make everything happen much faster, and electronic access makes journals
much more accessible, but the article PDF still looks much like the printed article
did when journals were invented, the peer-review system functions in much the
same way, subscription journals still make up 90% of the market. So much the
same I imagine.

well as to continue to develop our services and
tools for our library customers, our editors, societies, authors, and reviewers whilst managing
the spectacular growth in submissions.
ATG:  Tell us about SpringerOpen and its
impact on BioMed Central.   Is this a game
changer?
DK: SpringerOpen completes the openaccess publishing package from Springer,
giving authors the chance to publish in a
high-quality, open-access journal, whatever
their scientific discipline. It is “powered by”
BioMed Central — that is, it uses all of our
systems and processes but also benefits from
the powerful Springer branding in the areas
where Springer is a leading force. Since its
launch less than a year ago, SpringerOpen
has announced nearly 50 titles in mathematics,
engineering, information sciences, chemistry,
and other non-biomedical fields, and is proving to be a significant force in the open-access
publishing field.
ATG:  You are a mathematician by training.  Has OA journal been successful mathematically? How would you define success
in this case?
DK: According to Wikipedia, “mathematicians formulate new conjectures and resolve the
truth or falsity of them by proofs which are sufficient to convince others of their validity.” When
Vitek Tracz and Matt Cockerill started BioMed

Central in 2000, they believed that there was a
new publishing model that could work in journal
publishing which would allow open access to
research in a sustainable way. This has now been
proven without doubt. So, yes, OA publishing
has been successful mathematically.
ATG:  What does growing OA publishing
mean for small publishers?  Is OA their salvation or ruination?  Why or why not?
DK: Well, BioMed Central was only
launched 11 years ago, and until recently could
have been designated a small publisher. Now,
with nearly 300 staff and publishing 215 journals, we are probably medium-sized. So, as far
as this small publisher is concerned, OA has been
a good thing! In business, whatever size business
you are, you need to be able to meet the needs
of your customers. If you do, you thrive. If not,
you fail. The same is true for small publishers. If
customers want OA and they are not in a position
to provide it, they will fail.
ATG: To finish on a personal note, tell us
about yourself.  What do you do in your spare
time?  What do you like to read?
DK: I love to spend time with my partner
and dog walking in the country. I love to travel
and am looking forward to my summer holiday
walking in the hills in Southern Spain. I love
to read, listen to music, go to the theatre, and
eat great food.
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